Trial
NCT00547443
Sorafenib and High-Dose Carboplatin, Paclitaxel, and External-Beam Radiation Therapy in Treating Patients With Stage III Non-Small Cell Lung Cancer
Phase IWITHDRAWNOTHER/UNKNOWNConfidence: LOW
Sponsor
University of Texas Southwestern Medical Center
Collaborators
—
Condition
Lung Cancer
Intervention
carboplatin
Why stopped
Withdrawn as the sponsor has stopped the drug for NSCLC population
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2019-01-10